Xia, H., van den Hof, S., Cobelens, F., Zhou, Y., Zhao, B., Wang, S., & Zhao, Y. (2020). Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. BMC Infect Dis.
Citação norma ChicagoXia, Hui, Susan van den Hof, Frank Cobelens, Yang Zhou, Bing Zhao, Shengfen Wang, and Yanlin Zhao. "Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-resistant Mycobacterium Tuberculosis in China." BMC Infect Dis 2020.
MLA CitationXia, Hui, et al. "Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-resistant Mycobacterium Tuberculosis in China." BMC Infect Dis 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.